Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Zacks Initiates Coverage of Inspire Veterinary With Underperform Recommendation: https://staticx-tuner.zacks.com/images/articles/main/14/20228.jpg
Zacks Initiates Coverage of Inspire Veterinary With Underperform Recommendation

Zacks Investment Research has recently initiated coverage of Inspire Veterinary Partners Inc. IVP with an Underperform rating, citing persistent financial headwinds and structural challenges that

ABSI Stock Up on Initiating Dosing in Androgenetic Alopecia Study
ABSI Stock Up on Initiating Dosing in Androgenetic Alopecia Study

Shares of Absci Corporation ABSI jumped 13.4% on Thursday after the company initiated dosing in an early-to-mid-stage study evaluating its investigational candidate, ABS-201, for androgenetic

Will Crypto Miners Pivot to AI? Latest on 3 Key Players: https://www.marketbeat.com/logos/articles/med_20251204153154_will-crypto-miners-pivot-to-ai-latest-on-3-key-pla.png
Will Crypto Miners Pivot to AI? Latest on 3 Key Players

The worlds of cryptocurrency and artificial intelligence infrastructure are closely linked. A notable example is Strategy (NASDAQ: MSTR)—which recently made the controversial pivot from AI-linked

CAPR Stock Skyrockets 282% in a Week: Here's What You Need to Know
CAPR Stock Skyrockets 282% in a Week: Here's What You Need to Know

Shares of Capricor Therapeutics CAPR have skyrocketed 281.9% this week. The massive stock price surge was observed after the company reported positive top-line results from a late-stage study of

HPE Q4 Earnings Surpass Expectations, Revenues Rise Y/Y
HPE Q4 Earnings Surpass Expectations, Revenues Rise Y/Y

Hewlett Packard Enterprise HPE stock declined more than 8% in the pre-market hours despite reporting better-than-expected results for fourth-quarter fiscal 2025. The company’s non-GAAP earnings of

QBTS Fortifies Its Balance Sheet Amid Competition With IONQ, RGTI
QBTS Fortifies Its Balance Sheet Amid Competition With IONQ, RGTI

D-Wave Quantum’s QBTS third-quarter 2025 results show an improvement in the company’s operations. The company reported gross profit of $2.7 million, up 156% year over year. Meanwhile, GAAP gross

Why Revenue Durability Now Matters Most for Nu Holdings' Investors
Why Revenue Durability Now Matters Most for Nu Holdings' Investors

Nu Holdings’ NU strongest differentiator at this stage of its growth cycle is its rising revenue durability, the company’s ability to convert a massive customer base into recurring, multi-product

Netflix to Buy Warner Brothers for $72 Billion, PCE Data Delayed: https://staticx-tuner.zacks.com/images/articles/main/42/135424.webp
Netflix to Buy Warner Brothers for $72 Billion, PCE Data Delayed

Friday, December 5, 2025Pre-market futures had been up across the board, but have fallen off the table in recent minutes. We’re now 25 minutes before the opening bell, and we still have yet to see

Is Gap Positioned to Extend Its Q3 Sales Momentum as Key Brands Shine?
Is Gap Positioned to Extend Its Q3 Sales Momentum as Key Brands Shine?

Gap Inc. GAP delivered an impressive third-quarter fiscal 2025 performance, highlighted by broad-based strength across its key brands. Company-wide comps rose 5%, the highest in more than four

BNY Mellon Stock Hits 52-Week High: Is This the Right Time to Invest?
BNY Mellon Stock Hits 52-Week High: Is This the Right Time to Invest?

The Bank of New York Mellon Corporation’s BK shares touched a new 52-week high of $114.43 in Thursday’s trading session. Over the past six months, BK stock has gained 26.2%, outperforming the indust

Best Momentum Stocks to Buy for Dec.5
Best Momentum Stocks to Buy for Dec.5

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Dec. 5: 

Credo Technology Group Holding Ltd CRDO: This connectivity solutions provider has a

ASTS Shares Zoom on Upcoming BlueBird 6 Launch: Worth Buying Now?
ASTS Shares Zoom on Upcoming BlueBird 6 Launch: Worth Buying Now?

AST SpaceMobile, Inc. ASTS shares were up 18.3% yesterday, driven by the euphoria related to its upcoming BlueBird satellite launch on Dec. 15. The uptrend was also buoyed by OpenAI CEO Sam Altman’s

Capturing AI Gains Without Overexposure: ETFs to Consider
Capturing AI Gains Without Overexposure: ETFs to Consider

The market’s rally has been fueled by AI for quite some time now, with the “Magnificent Seven” significantly outperforming the S&P 500 and accounting for much of the gains. This outperformance is

Biotech ETF (XBI) Hits New 52-Week High
Biotech ETF (XBI) Hits New 52-Week High

For investors seeking momentum, State Street SPDR S&P Biotech ETF XBI is probably on the radar. The fund just hit a 52-week high and has risen 85.43% from its 52-week low price of $66.66/share.

But

KBR Secures $117M U.S. Navy Contract to Support Global F/A-18 Fleet
KBR Secures $117M U.S. Navy Contract to Support Global F/A-18 Fleet

KBR, Inc. KBR has expanded its U.K. presence after securing a U.S. Navy contract to provide Foreign Military Sales support for the Naval Air Systems Command’s (NAVAIR) F/A-18 and EA-18G Program

Can Galafold Continue to Drive Amicus' Top Line in 2026?
Can Galafold Continue to Drive Amicus' Top Line in 2026?

Amicus Therapeutics FOLD has been making meaningful progress with its lead product, Galafold (migalastat), which has been driving the majority of the company’s revenues. The drug has remained a key

Denali Enters Into a $275M Funding Deal With Royalty Pharma
Denali Enters Into a $275M Funding Deal With Royalty Pharma

Denali Therapeutics Inc. DNLI has announced a funding agreement with Royalty Pharma plc RPRX for $275 million. The stock gained 5.84% following the announcement.

The deal centers on future net sales

Wall Street Analysts Predict an 87.48% Upside in Benitec Biopharma (BNTC): Here's  What You Should Know
Wall Street Analysts Predict an 87.48% Upside in Benitec Biopharma (BNTC): Here's What You Should Know

Benitec Biopharma Limited (BNTC) closed the last trading session at $13.18, gaining 9.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Wall Street Analysts Think Profound Medical (PROF) Could Surge 82.37%: Read This Before Placing a Bet
Wall Street Analysts Think Profound Medical (PROF) Could Surge 82.37%: Read This Before Placing a Bet

Profound Medical (PROF) closed the last trading session at $6.75, gaining 15.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Does Theravance Bio (TBPH) Have the Potential to Rally 30.64% as Wall Street Analysts Expect?
Does Theravance Bio (TBPH) Have the Potential to Rally 30.64% as Wall Street Analysts Expect?

Shares of Theravance Biopharma (TBPH) have gained 25.8% over the past four weeks to close the last trading session at $18.7, but there could still be a solid upside left in the stock if short-term

ATN International (ATNI) Just Flashed Golden Cross Signal: Do You Buy?
ATN International (ATNI) Just Flashed Golden Cross Signal: Do You Buy?

From a technical perspective, ATN International, Inc. (ATNI) is looking like an interesting pick, as it just reached a key level of support. ATNI's 50-day simple moving average crossed above its

Wall Street Analysts Think Atlassian (TEAM) Could Surge 50.43%: Read This Before Placing a Bet
Wall Street Analysts Think Atlassian (TEAM) Could Surge 50.43%: Read This Before Placing a Bet

Shares of Atlassian (TEAM) have gained 0.3% over the past four weeks to close the last trading session at $156.54, but there could still be a solid upside left in the stock if short-term price

Should You Buy Si-Bone (SIBN) After Golden Cross?
Should You Buy Si-Bone (SIBN) After Golden Cross?

After reaching an important support level, SiBone (SIBN) could be a good stock pick from a technical perspective. SIBN recently experienced a "golden cross" event, which saw its 50-day simple moving

Wall Street Analysts See a 29.72% Upside in Archer Aviation (ACHR): Can the Stock Really Move This High?
Wall Street Analysts See a 29.72% Upside in Archer Aviation (ACHR): Can the Stock Really Move This High?

Archer Aviation Inc. (ACHR) closed the last trading session at $8.95, gaining 0.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Transportadora De Gas Sa Ord B (TGS) Just Flashed Golden Cross Signal: Do You Buy?
Transportadora De Gas Sa Ord B (TGS) Just Flashed Golden Cross Signal: Do You Buy?

Transportadora De Gas Sa Ord B (TGS) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, TGS's 50-day simple moving average